With an estimated 6474 million people suffering a traumatic brain injury (TBI) annually, TBI is a major cause of death and disability and a global public health concern [5]
Lung cancer in patients who have never smoked an emerging disease
Novo Nordisk is committed to the responsible use of our semaglutide-containing medicines which represent distinct products with different indications, dosages, prescribing information, titration schedules, and delivery forms
however, after the appearance of prospective randomized studies that indicated an increase in the incidence of breast cancer, the establishment of this therapy has been adjusted to the presence of certain risk factors, symptoms, and the evolution of patients (Zhao and Brinton, 2006)
Retatrutide is administered once weekly via subcutaneous injection